Consider what a single hospital ward of 30 beds consumes every 24 hours: IV fluid sets, syringes, surgical gloves, wound dressings, urine collection bags, oxygen masks, catheter kits, and disposable gowns -- each used once and discarded for infection control. Multiply that by 75,000 hospitals and nursing homes operating across India, add 1.5 lakh government health and wellness centres under Ayushman Bharat, and factor in the 14,000+ hospitals being added under PM Ayushman Bharat Health Infrastructure Mission -- and the scale of recurring demand for medical disposables becomes clear. This is not discretionary consumption. This is essential, daily, non-negotiable procurement.

For a manufacturing entrepreneur, medical disposables and surgical products manufacturing in India offers entry poi

...

Consider what a single hospital ward of 30 beds consumes every 24 hours: IV fluid sets, syringes, surgical gloves, wound dressings, urine collection bags, oxygen masks, catheter kits, and disposable gowns -- each used once and discarded for infection control. Multiply that by 75,000 hospitals and nursing homes operating across India, add 1.5 lakh government health and wellness centres under Ayushman Bharat, and factor in the 14,000+ hospitals being added under PM Ayushman Bharat Health Infrastructure Mission -- and the scale of recurring demand for medical disposables becomes clear. This is not discretionary consumption. This is essential, daily, non-negotiable procurement.

For a manufacturing entrepreneur, medical disposables and surgical products manufacturing in India offers entry points at multiple capital levels: non-woven surgical drapes and gowns can be started at Rs. 25-50 lakh; IV administration sets at Rs. 75 lakh to Rs. 1.5 crore; syringe manufacturing at Rs. 1-3 crore; and advanced catheter or drainage bag production at Rs. 2-5 crore. Each sub-category has a clear, structured buyer base -- government hospitals (through GeM and CGMSC tenders), private hospital chains, and export buyers in Africa, Southeast Asia, and the Middle East.

Why Medical Disposables Manufacturing Is India's Most Healthcare-Backed Manufacturing Opportunity

Medical disposables and hospital consumables manufacturing in India is supported by the most significant expansion of healthcare infrastructure in the country's history -- with Ayushman Bharat PM-JAY covering 55 crore beneficiaries, the PM-ABHIM scheme adding 17,788 new health facilities, and India's medical tourism industry attracting global patients who demand international-standard consumables.

The numbers are compelling. India's medical devices market was valued at USD 12 billion in 2024 (Ministry of Chemicals and Fertilisers), growing at approximately 15% annually. Medical devices exports were USD 3.0 billion in FY2023-24 (Pharmexcil / DGCI&S). However, India still imports approximately USD 8-9 billion worth of medical devices annually -- creating a massive import substitution opportunity that the PLI scheme (Rs. 3,420 crore) and Medical Devices Park scheme are specifically designed to address.

The COVID-19 pandemic was a turning point for Indian medical device manufacturing. Before COVID, India imported over 90% of N-95 masks, surgical gowns, ventilators, and oximeters. By 2021, domestic production of all these categories had been established or significantly scaled. The Atmanirbhar Bharat initiative and PLI for medical devices ensured this domestic capacity persisted beyond the pandemic -- giving the Indian medical device manufacturing industry its first sustained production base in many critical consumable categories.

Ayushman Bharat PM-JAY is the most significant demand driver for hospital consumables. With 55 crore beneficiaries (the world's largest health insurance scheme) covered for secondary and tertiary hospitalisation, the scheme funds treatments that require disposables consumption at every stage. As PM-JAY empanelled hospitals (25,000+ as of 2024) treat more patients under the scheme, their disposables procurement scales in direct proportion.

Medical tourism is an additional demand driver. India treats approximately 5 lakh international medical tourists annually (Ministry of Tourism data), primarily for cardiac surgery, orthopedic procedures, and oncology. International patients and the accredited hospitals (JCI and NABH-accredited) serving them demand international-quality medical consumables -- creating a premium product segment within the domestic hospital supply chain.

Ayushman Bharat PM-JAY: The Healthcare Scheme Driving Disposables Demand Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) -- the world's largest government health insurance scheme -- covers 55 crore beneficiaries (approximately 12 crore families) for hospitalisation up to Rs. 5 lakh per family per year. Over 25,000 hospitals are empanelled under PM-JAY nationally. The scheme has enabled 6+ crore hospitalisations since launch in 2018. Each hospitalisation requires a standard set of disposable consumables: IV sets, syringes, gloves, wound care dressings, and patient care items. The PM-ABHIM (Pradhan Mantri Ayushman Bharat Health Infrastructure Mission) adds 17,788 new health facilities with Rs. 64,180 crore investment. Together these schemes represent the most transformative expansion of India's healthcare infrastructure -- and disposables demand -- in history. (National Health Authority; Ministry of Health and Family Welfare)

The PLI Scheme for Medical Devices (Rs. 3,420 crore, 4 years) covers 'critical care' medical devices including disposables. Manufacturers producing PLI-covered products with minimum incremental sales get 5% incentive on incremental sales for 5 years. The scheme specifically targets import substitution in high-value devices -- but the manufacturing ecosystem development it drives also benefits MSME disposable manufacturers who serve the component and consumable supply chains of PLI-beneficiary device manufacturers.

Market Demand, Growth and Statistical Evidence

India's medical disposables market is growing at 15%+ annually, driven by healthcare infrastructure expansion, Ayushman Bharat hospitalisation growth, medical tourism, and rising health consciousness among urban consumers.

India's medical devices market -- of which disposables and consumables represent approximately 40-45% by value -- was USD 12 billion in 2024. The market is projected to reach USD 50 billion by 2030 (Ministry of Chemicals and Fertilisers Vision Document), at approximately 15% CAGR. This would make India one of the top five medical device markets globally.

Disposable syringes and needles represent one of the highest-volume categories. India produces approximately 10-12 billion disposable syringes annually (Pharmexcil estimate) -- one of the largest volumes in the world. India is also a significant syringe exporter, primarily to Africa and Southeast Asia, where Indian-produced syringes (WHO prequalified, ISO 7886 certified) serve government immunisation programmes.

Year-Wise India Medical Devices Market and Export Data

Year	Medical Devices Market (USD Bn)	Medical Device Exports (USD Bn)	Key Driver
FY2019-20	~7.5	~2.0	Hospital expansion; PM-JAY launch and ramp-up
FY2020-21	~8.5	~2.3	COVID -- PPE, mask, ventilator manufacturing surge
FY2021-22	~9.5	~2.6	Post-COVID hospital restocking; syringe exports for vaccine rollout
FY2022-23	~10.5	~2.8	PM-ABHIM implementation; medical tourism recovery
FY2023-24	~12.0	~3.0	Pharmexcil data; PLI ramp-up; PM-JAY empanelments grow
FY2025 (est.)	~14.0	~3.5	PLI beneficiaries scaling output; Africa syringe exports
FY2027 (forecast)	~18.5	~5.0	Assumed 15% CAGR; Medical Device Parks operational
FY2030 (forecast)	~50.0 (govt target)	~12.0	Ministry target; import substitution achieved in many categories
FY2033 (forecast)	~65.0	~18.0	Stated estimate at 10% CAGR from FY2030 target base
FY2035 (forecast)	~80.0	~25.0	India top-5 medical device market globally

Note: Historical market size and export data from Pharmexcil and Ministry of Chemicals. FY2030 target is Ministry of Chemicals stated goal. FY2035 is a stated estimate using 10% CAGR from the FY2030 target.

India Syringe Manufacturing: A World-Scale Export Industry India produces approximately 10-12 billion disposable syringes annually -- among the world's largest outputs. India is a major WHO-prequalified syringe exporter, supplying government immunisation programmes in Africa, Southeast Asia, and the Middle East. Syringe manufacturers in Baddi (Himachal Pradesh) and Dehradun cluster supply both domestic hospital procurement and significant export volumes. Auto-disable (AD) syringes -- which cannot be reused -- are a specific WHO-promoted product for developing country immunisation programmes, and India's AD syringe producers (HMD Healthcare, Hindustan Syringes) are major global suppliers. (Pharmexcil; WHO PQ programme; DGCI&S export data)

What Government Data Reveals About Medical Disposables Business Opportunity

Ministry of Health and Family Welfare, National Health Authority, CDSCO, and Pharmexcil data together confirm that India's healthcare expansion is creating the largest sustained increase in medical disposables demand in the country's history.

National Health Authority data confirms that PM-JAY has enabled over 6 crore hospitalisation events since 2018. Each hospitalisation event consumes a standardised set of disposable consumables -- IV administration sets (1-3 per patient), syringes (5-20 per patient), wound dressings (multiple), gloves (surgical and examination), and patient care items. The average consumable cost per hospitalisation is estimated at Rs. 800-2,000 depending on procedure type -- implying Rs. 4,800-12,000 crore of annual consumable demand generated by PM-JAY hospitalisations alone.

The PM-ABHIM scheme (Rs. 64,180 crore for health infrastructure) is adding 17,788 new health facilities -- critical care hospital blocks, district hospitals, and primary health centre upgrades -- all requiring initial stocking and ongoing replenishment of medical consumables. Ministry of Health procurement for government hospitals flows through the Central Government Medical Stores Organisation (CGMSO) and state medical supply corporations -- both of which procure through GeM and rate contract tenders.

CDSCO data shows that India's medical device regulatory ecosystem, significantly strengthened by the Medical Devices Rules 2017, now has over 15,000 registered medical devices and manufacturers -- but import substitution remains a priority as India still imports USD 8-9 billion of medical devices and disposables annually from the USA, Germany, Japan, and China.

Government & Department Statistics: Medical Devices and Disposables Sector

Indicator	Figure	Source & Year
India Medical Devices Market (2024)	USD 12 billion	Ministry of Chemicals and Fertilisers
India Medical Device Exports (FY2023-24)	USD 3.0 billion	Pharmexcil / DGCI&S
India Medical Device Imports (FY2023-24)	~USD 8-9 billion	Ministry of Chemicals / DGCI&S
PLI Scheme for Medical Devices	Rs. 3,420 crore; 5% incentive on incremental sales	Ministry of Chemicals and Fertilisers
PM-JAY Beneficiaries	55 crore (12 crore families)	National Health Authority, 2024
PM-JAY Empanelled Hospitals	25,000+	National Health Authority, 2024
PM-JAY Hospitalisations (cumulative)	6+ crore since 2018	National Health Authority
PM-ABHIM Investment	Rs. 64,180 crore for 17,788 facilities	Ministry of Health and Family Welfare
Government Medical Devices Target (2030)	USD 50 billion market	Ministry of Chemicals Vision Document

For a medical disposables manufacturer, the most actionable government data is the PM-JAY hospitalisation figure -- 6 crore hospitalisations since 2018 and growing annually. This is a government-funded, scale-proven demand base that directly drives hospital procurement of disposable consumables. And the PM-ABHIM's 17,788 new health facilities represent a procurement wave just beginning.

Government Schemes and Incentives for Medical Disposables Manufacturers

Medical disposables manufacturers benefit from PLI incentives, Medical Device Parks, GeM procurement access, Pharmexcil export facilitation, and dedicated CDSCO regulatory streamlining.

1. PLI Scheme for Medical Devices (Rs. 3,420 crore): Covers critical care medical devices including many disposable categories. Manufacturers producing PLI-covered products with minimum incremental sales of Rs. 10 crore receive 5% incentive on incremental sales for 5 years. MSME manufacturers who aggregate multiple PLI-covered disposable products can structure their production to qualify. Applications are processed by the Ministry of Chemicals and Fertilisers.

2. Medical Device Parks (MDP) Scheme: Four Medical Device Parks are being developed at Andhra Pradesh, Telangana, Tamil Nadu, and Himachal Pradesh with Government of India grant funding (maximum Rs. 100 crore per park). These parks provide plug-and-play manufacturing infrastructure, common testing facilities (NABL-accredited labs), and sterilisation services shared among park tenants -- significantly reducing per-unit compliance and testing costs for MSME medical device manufacturers.

3. GeM and Government Hospital Procurement: Central Government Medical Stores Organisation (CGMSO) and state medical supply corporations procure through GeM. CDSCO-licensed, BIS-certified disposables can be listed on GeM for government hospital procurement. Rate contracts for standard items (IV sets, syringes, gloves, wound dressings) are awarded annually through government tenders -- providing multi-year supply certainty for empanelled manufacturers.

4. Pharmexcil Export Facilitation: Pharmaceutical Export Promotion Council of India (Pharmexcil) under the Ministry of Commerce facilitates medical device exports including disposables. Services include: WHO prequalification support for syringe and IV set exporters, participation in international healthcare trade fairs (Arab Health Dubai, Medica Dusseldorf, Medexpo Africa), and export market intelligence for African and Southeast Asian government tender participation.

5. CGTMSE and MSME Credit: Medical disposables manufacturing being capital-intensive for clean room setup and sterilisation equipment requires significant upfront investment. CGTMSE collateral-free credit up to Rs. 2 crore supports initial equipment financing. For larger MSME units, SIDBI's SMILE scheme (SIDBI Make in India Soft Loan Fund for MSMEs) provides term loans for manufacturing capacity creation.

Import and Export Opportunity in Medical Disposables Manufacturing

India's medical disposables sector has a proven export history in syringes and basic consumables -- and significant import substitution opportunity in higher-value disposables where India currently imports from China, Germany, and the USA.

India's medical device exports were USD 3.0 billion in FY2023-24 (Pharmexcil). Key export categories include disposable syringes (the largest single category), IV sets and infusion fluid systems, surgical gloves, wound care dressings, and non-woven surgical consumables. Primary export markets are USA (largest), Germany, UK, France, UAE, and African countries (Nigeria, Kenya, South Africa, Ethiopia) through UNICEF and WHO-procured immunisation programmes.

On the import side, India imports advanced disposables including specialty catheters (cardiac, urological), advanced wound care dressings, specialty IV access devices, and precision diagnostic disposables from the USA, Germany, Japan, and China. Import substitution in catheters, drainage bags, and specialty wound care is a specific government priority under the PLI scheme. MSME manufacturers investing in any of these currently-imported categories enter a market where domestic competition is limited and government preference through 'Make in India' procurement policy actively supports Indian manufacturers.

Africa is a particularly high-growth export market for Indian medical disposables. African government health ministries and UNICEF/WHO procurement agents buy syringes, IV sets, surgical gloves, and basic disposables from India in large volumes through tender-based procurement. Pharmexcil actively supports Indian manufacturers in responding to African government health ministry tenders -- providing tender information, documentation support, and quality prequalification guidance.

Major Indian Medical Disposables Manufacturers

Company	Segment / Note
Hindustan Syringes (Faridabad)	Disposable syringes; leading Indian producer; WHO prequalified; large exports
HMD Healthcare (Baddi)	Auto-disable and standard syringes; significant Africa exports
Romsons (Agra)	IV sets, urine bags, drainage bags; comprehensive hospital disposables
Dispovan (Becton Dickinson India)	Syringes, needles; international quality; hospital and institutional
Poly Medicure (Faridabad)	IV sets, blood bag systems, catheters; listed; large export base
Neon Surgical (Gujarat)	Surgical drapes, gowns, non-woven disposables; OT products
Mediply / Suru International (Mumbai)	Examination gloves, surgical gloves; hospital supply chain
MSME non-woven units (Tamil Nadu, Gujarat)	Surgical drapes, masks, gowns; OEM supply to hospital brands

The Growth Horizon: Medical Disposables Market to 2035

India's medical devices market is targeting USD 50 billion by 2030 (Ministry of Chemicals vision) -- with disposables and consumables maintaining approximately 40-45% of this market at USD 20-22 billion in medical disposables and consumables by 2030

The PM-ABHIM investment of Rs. 64,180 crore in 17,788 new health facilities will drive a wave of procurement through 2027-2030 as each facility is commissioned and requires initial stocking and then ongoing consumable replenishment. Combined with PM-JAY's growing hospitalisation volumes and India's expanding medical tourism, the demand trajectory is among the clearest in any manufacturing sector.

Export growth will be driven by three forces through 2035: African health infrastructure investment (World Bank and African Development Bank-funded hospital programmes procuring disposables at scale), India's WHO prequalification expanding to more product categories, and the China+1 effect as global hospital procurement chains seek alternative sources for medical consumables beyond Chinese supply.

The premium domestic segment -- JCI-accredited hospitals, medical tourism facilities, and corporate hospital chains -- is growing and demanding higher-specification disposables including specialty catheters, advanced wound care, and precision IV access devices. Indian manufacturers who invest in these higher-value categories reduce competition from commodity Chinese imports and access a domestic premium segment with better margins.

CDSCO Licensing Is Non-Negotiable -- Start This Process Before Plant Construction Every medical device and disposable product sold in India must be registered under the Medical Devices Rules 2017 and a CDSCO licence obtained. The CDSCO licensing process requires: product risk classification (Class A, B, C, or D based on risk), manufacturing site approval (CDSCO inspects the manufacturing facility), product standard compliance (ISO 13485 quality management system is mandatory), and clinical performance data for higher-risk classes. The CDSCO licensing process takes 3-12 months depending on product class. Starting the CDSCO registration process before your facility is commissioned -- as early as the plant design stage -- is essential. Operating without a CDSCO licence is a criminal offence under the Drugs and Cosmetics Act.

Practitioner Q&A: Medical Disposables and Surgical Products Manufacturing

Q1: What is the most MSME-accessible product category in medical disposables?

Non-woven hospital consumables -- surgical drapes, disposable gowns, isolation gowns, face masks, and surgical packs -- are among the most MSME-accessible categories. Technology is based on spunbond non-woven fabric cutting, stitching, and packaging -- similar to technical textile manufacturing. Raw material (PP spunbond and SMS fabric) is available domestically. CDSCO Class A/B device classification for these products has simpler licence requirements than high-risk devices. Starting capital: Rs. 25-75 lakh for a small OT textile disposables unit. COVID established a large domestic producer base for these products -- the challenge for new entrants is differentiation through quality and hospital accreditation compliance.

Q2: What is the CDSCO licensing process for medical device manufacturers?

The Medical Devices Rules 2017 classify all medical devices into four risk classes: Class A (low risk -- simple devices like gauze, surgical drapes), Class B (low-moderate risk -- syringes, IV sets, examination gloves), Class C (moderate-high risk -- catheters, infusion pumps), and Class D (high risk -- implantables, cardiac devices). Manufacturers must obtain a Manufacturing Licence from the State Licensing Authority (for Class A and B) or CDSCO central (for Class C and D). The process requires ISO 13485 Quality Management System certification, facility inspection by CDSCO/SLA inspectors, product standard compliance, and for Class C/D, clinical performance evidence. Build 6-12 months into your timeline for CDSCO approval before product launch.

Q3: What is the IV administration set manufacturing opportunity?

IV (intravenous) administration sets are used for fluid infusion in every hospital ward and emergency room. India's hospital bed count is approximately 1.9 million beds (NHP data) -- each bed potentially using 1-3 IV sets per patient admission day. The domestic IV set market is served by Romsons, Poly Medicure, and several MSME manufacturers. An IV set manufacturing unit requires clean room infrastructure (ISO Class 7 or 8 environment), CDSCO Class B device licence, and strict quality control for particle contamination. Investment: Rs. 75 lakh to Rs. 2 crore for a basic IV set line. WHO prequalification opens export markets for IV sets in African government procurement programmes.

Q4: How can an MSME medical disposables manufacturer supply government hospitals?

Government hospital supply in India flows through three channels: Central Government Medical Stores Organisation (CGMSO) rate contracts, state medical supply corporations (TNMSC in Tamil Nadu, KMSCL in Kerala, BNPL in West Bengal), and GeM (Government e-Marketplace) for smaller procurement. Rate contracts are awarded through competitive tender processes for standardised disposables -- manufacturers qualifying on technical specifications, CDSCO licence, BIS/ISO certification, and price submit bids. GeM listing for standard items allows direct purchase orders from individual government hospitals. CGHS (Central Government Health Scheme) procurement is another government channel accessible to CDSCO-licensed manufacturers.

Q5: What are WHO prequalification and why is it important for syringe exporters?

WHO Prequalification (PQ) for medical devices is an international quality certification that signals product safety and efficacy compliance for use in international public health programmes. For syringes, WHO-PQ (using ISO 7886 or 23908 standard) is required to supply UNICEF, WHO, and national immunisation programmes in African and Asian developing countries. These programmes buy hundreds of millions of syringes annually at fixed prices through international tenders. India's WHO-PQ-certified syringe manufacturers (Hindustan Syringes, HMD Healthcare) win large portions of these tenders. An MSME syringe manufacturer achieving WHO-PQ status gains access to the most stable, large-volume export procurement channel available in the medical device export market.

Q6: What raw materials are used in medical disposables manufacturing?

IV sets and syringes use medical-grade polypropylene (PP) and polyvinyl chloride (PVC) as primary polymers -- available from domestic suppliers (Reliance, HPCL-Mittal) and importers. Non-woven hospital textiles use PP spunbond and SMS fabric available from Indian non-woven fabric producers. Surgical gloves use natural latex (from Kerala) or nitrile rubber (imported). Needle manufacturing uses stainless steel tubing (304 or 316L grade) imported from Japan or domestic specialty suppliers. Ethylene oxide (EtO) or gamma radiation sterilisation services are available through contract sterilisers at Medical Device Parks or industrial sterilisation facilities.

Q7: What is the examination glove manufacturing opportunity in India?

Examination gloves (nitrile, latex, and vinyl) are consumed in enormous volumes in hospitals, laboratories, dental clinics, and industrial safety applications. India imports a large proportion of examination gloves from Malaysia and Thailand (the world's largest latex glove producers). Post-COVID, domestic production has grown but import dependency remains high, particularly for nitrile gloves. A domestic examination glove manufacturer invests in dipping lines (latex or nitrile dipping tanks, drying ovens, chlorination lines). Investment: Rs. 3-10 crore for a small glove manufacturing line. CDSCO Class B device licence required. The domestic market is large and growing -- healthcare, diagnostics, food processing, and beauty service industries all use examination gloves.

Q8: How does medical tourism drive premium disposables demand in India?

India attracts approximately 5 lakh international medical tourists annually (Ministry of Tourism data), primarily for cardiac surgery, orthopedic procedures, transplants, and oncology. These patients are treated in JCI-accredited hospitals (Apollo, Fortis, Manipal, Narayana) that specify international-standard medical consumables to maintain accreditation. Premium disposables -- minimally invasive surgical trocars, advanced wound closure strips, antimicrobial dressings, specialty catheters -- are purchased by these hospitals at premium prices with strict quality requirements. MSME manufacturers who achieve ISO 13485 and CE marking (European medical device certification) can supply these premium hospital accounts, competing with imported products on service, availability, and customisation.

Q9: Is the wound care dressings market accessible for MSMEs?

Standard wound care dressings (absorbent cotton gauze, cotton wool rolls, bandages, adhesive plasters) are manufactured by hundreds of MSMEs across India. The technology is simple, raw materials (medical-grade cotton, non-woven fabric, adhesive) are locally available, and the market is large with both government hospital procurement and retail pharmacy sales. CDSCO Class A device licence is required. BIS IS:1060 for surgical gauze and IS:6880 for medical bandages are applicable standards. Advanced wound care (hydrocolloid dressings, foam dressings, silver dressings) is a premium segment partially imported -- an MSME manufacturing advanced wound dressings with appropriate ISO 13485 certification accesses a less crowded, higher-margin segment.

Q10: What is the opportunity in dental disposables manufacturing?

Dental consumables -- disposable examination gloves, disposable bibs, suction tips, scalers, dental mirrors, probes, and evacuation tips -- are consumed in over 3 lakh dental clinics operating across India. India is training approximately 30,000 dentists per year (Dental Council of India data), and dental clinics are expanding rapidly in Tier 2 and Tier 3 cities. An MSME producing dental disposables serves both the domestic dental clinic market and export buyers in Middle Eastern and African markets where Indian dental products are competitive on price. CDSCO Class A and B device licences cover most dental consumables.

Q11: What is the hospital OT (operation theatre) consumables opportunity?

Operation theatre consumables -- surgical drapes (sterile field creation), gowns, instrument covers, light handle covers, table covers, and procedure packs (bundled OT kits) -- are consumed in every surgical procedure. India performs approximately 25-30 million surgical procedures annually (NHP estimate). Procedure packs (combining multiple disposable items in a sterile, ready-to-open kit) are a growing hospital preference because they reduce preparation time and waste. Assembling procedure packs from individual components -- sterile field drapes, instrument covers, patient positioning pads, and suction tubes -- and selling as a sterile kit is an MSME value-adding opportunity accessible with CDSCO Class B licence and EtO sterilisation access.

The Bottom Line

India's medical disposables sector is at the centre of the country's most ambitious healthcare expansion: Ayushman Bharat PM-JAY with 55 crore beneficiaries, PM-ABHIM adding 17,788 health facilities, and the USD 50 billion medical devices market target by 2030.

The single strongest reason to enter medical disposables manufacturing now is the PM-ABHIM procurement wave -- 17,788 new health facilities being commissioned through 2027, each requiring initial stocking and then ongoing consumable replenishment. This is government-funded, programmed demand that no commercial hospital expansion programme could match in scale or certainty.

Government support is comprehensive: PLI provides turnover incentives, Medical Device Parks provide shared infrastructure, Pharmexcil facilitates export, and CGMSO/GeM provide government procurement channels. Your most critical first step is CDSCO licensing -- start this process at the plant design stage, not after commissioning. Choose your product category, understand its risk class, engage a regulatory consultant experienced in Medical Devices Rules 2017, and get the ISO 13485 process underway before your first machine is installed.

References

• Ministry of Chemicals and Fertilisers, Government of India -- India medical devices market (USD 12 billion, 2024); USD 50 billion target by 2030; PLI Scheme for Medical Devices (Rs. 3,420 crore); Medical Device Parks scheme
• National Health Authority (NHA), Government of India -- PM-JAY (55 crore beneficiaries, 25,000+ empanelled hospitals, 6+ crore hospitalisations); PM-ABHIM (Rs. 64,180 crore, 17,788 health facilities)
• Pharmexcil (Pharmaceutical Export Promotion Council of India), Ministry of Commerce -- Medical device exports (USD 3.0 billion FY2023-24); WHO prequalification support; Medica Dusseldorf participation
• CDSCO (Central Drugs Standard Control Organisation), Ministry of Health and Family Welfare -- Medical Devices Rules 2017; device risk classification; manufacturing licence requirements; ISO 13485 mandate
• Ministry of Health and Family Welfare, Government of India -- National Health Policy; India hospital bed count; CGHS procurement framework; government hospital supply chain
• DGCI&S (Directorate General of Commercial Intelligence and Statistics), Ministry of Commerce -- Medical device import data (USD 8-9 billion FY2023-24); syringe and IV set export destination statistics